MedTrace Logo

Immersive Versus Passive Virtual Reality on Upper Limb Pain and Range of Motion in Pediatric Burn

NCT06612892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-09-25

No results posted yet for this study

Summary

The purpose of the present study was to declare the difference between using immersive virtual reality vs passive virtual reality on pain management and improvement of ROM post physiotherapy exercise and mobilization sessions in pediatric burn patients.

Conditions

  • Virtual Reality
  • Immersive Virtual Reality
  • Pediatric Burn
  • Passive Virtual Reality

Interventions

DEVICE

Virtual reality games in immersive VR modality

virtual reality involved three characters: a muscular boxer, a superhero, and a rock climber, with patients performing tasks in standing or sitting. Each experience takes 6 minutes, with 5-minute intervals between. Experimenters will instruct users on hand controls and virtual body observation.

DEVICE

Virtual reality show in passive VR modality:

In this modality the patient was asked to have a comfortable seat wearing the head set without holding the controllers , the therapist will play a relaxing show as a nature view or colorful scene as a sort of relaxation and mind distraction for around 20 minutes while asking the patient to perform upper limb muscle ROM exercise in active or active assisted form.

OTHER

traditional physiotherapy

Includes stretching exercise for upper limb muscles affected by burn, scar tissue release , and splinting technique.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-10
Primary Completion
2024-06-10
Completion
2024-09-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06612892 on ClinicalTrials.gov